MX378168B - Un extracto de indigo naturalis y un proceso para preparar el mismo. - Google Patents

Un extracto de indigo naturalis y un proceso para preparar el mismo.

Info

Publication number
MX378168B
MX378168B MX2017012595A MX2017012595A MX378168B MX 378168 B MX378168 B MX 378168B MX 2017012595 A MX2017012595 A MX 2017012595A MX 2017012595 A MX2017012595 A MX 2017012595A MX 378168 B MX378168 B MX 378168B
Authority
MX
Mexico
Prior art keywords
extract
preparing
indigo naturalis
same
composition
Prior art date
Application number
MX2017012595A
Other languages
English (en)
Other versions
MX2017012595A (es
Inventor
Antoine Bily
Isabelle Cardinaud
Jean- Thomas PIERSON
Laurent Chantalat
Bronec Loïc Le
Philippe Andres
Yin- Ku Lin
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2017012595A publication Critical patent/MX2017012595A/es
Publication of MX378168B publication Critical patent/MX378168B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)

Abstract

La presente invención se refiere a un proceso para preparar un extracto de una o más materias primas botánicas, tales como Indigo Naturalis y su propio extracto. La presente invención se refiere también a una composición que comprende el extracto, así como al uso de la composición en aplicaciones médicas o cosméticas.
MX2017012595A 2015-04-09 2016-04-08 Un extracto de indigo naturalis y un proceso para preparar el mismo. MX378168B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15163060 2015-04-09
PCT/EP2016/057761 WO2016162484A1 (en) 2015-04-09 2016-04-08 An extract from indigo naturalis and a process for preparing the same

Publications (2)

Publication Number Publication Date
MX2017012595A MX2017012595A (es) 2018-01-09
MX378168B true MX378168B (es) 2025-03-10

Family

ID=52874982

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012595A MX378168B (es) 2015-04-09 2016-04-08 Un extracto de indigo naturalis y un proceso para preparar el mismo.

Country Status (23)

Country Link
US (3) US9861673B2 (es)
EP (2) EP3209313B1 (es)
JP (1) JP6820273B2 (es)
KR (1) KR20170133497A (es)
CN (1) CN107427545A (es)
AU (1) AU2016245203B2 (es)
BR (1) BR112017021191B1 (es)
CA (1) CA2981624A1 (es)
CY (1) CY1121187T1 (es)
DK (1) DK3209313T3 (es)
ES (1) ES2709359T3 (es)
HR (1) HRP20190088T1 (es)
HU (1) HUE041308T2 (es)
LT (1) LT3209313T (es)
MX (1) MX378168B (es)
PL (1) PL3209313T3 (es)
PT (1) PT3209313T (es)
RS (1) RS58304B1 (es)
SI (1) SI3209313T1 (es)
SM (1) SMT201900054T1 (es)
TR (1) TR201901146T4 (es)
TW (1) TWI732754B (es)
WO (1) WO2016162484A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10668120B2 (en) 2015-04-09 2020-06-02 Galderma Sa Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
KR20170132880A (ko) 2015-04-09 2017-12-04 갈데르마 소시에떼아노님 약학 조성물 및 이의 용도
JP6820273B2 (ja) 2015-04-09 2021-01-27 ガルデルマ・ソシエテ・アノニム インジゴ・ナチュラリス由来のエキス及びそれを調製する方法
US20200009210A1 (en) * 2016-12-20 2020-01-09 Seoul National University Hospital Pharmaceutical Composition Comprising Indigo Pulverata Levis Extract or Fraction Thereof as Effective Ingredient for Preventing or Treating Inflammatory Bowel Disease
KR20210150829A (ko) 2020-06-04 2021-12-13 경성대학교 산학협력단 참당귀 추출물 및 인디루빈 농축물을 포함하는 건선 또는 비염치료용 조성물
CN113009035B (zh) * 2021-03-04 2022-08-02 福建卫生职业技术学院 基于目标成分敲出的中药药效组分辨识的方法及应用
CN113101879A (zh) * 2021-03-29 2021-07-13 李健昕 一种板蓝根挥发油微胶囊的制备
WO2023170714A1 (en) * 2022-03-10 2023-09-14 Joy Vadakkan Thomas A topical herbal composition for fungal infection, scaling, foot cracking, eczema and dry skin diseases
GB202306158D0 (en) 2023-04-26 2023-06-07 Givaudan Sa Process
CN117269380A (zh) * 2023-08-18 2023-12-22 复旦大学 一种高效萃取大气膜样品中有机组分的方法
CN120131870A (zh) * 2023-12-11 2025-06-13 华药君康有限公司 一种治疗银屑病的中药组合物及其制备方法和用途

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02264727A (ja) * 1989-04-04 1990-10-29 Ichimaru Pharcos Co Ltd 植物抽出物からなる過酸化脂質生成抑制剤
US6524625B2 (en) 1998-06-30 2003-02-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyuto Physiologically active extract obtained from indigo plant polygonum tinctorium
AU3548900A (en) 1999-04-14 2000-11-14 Max Zeller & Sohne Ag Medicament for inhibiting NF-kappaB
CN1317322A (zh) 2000-04-11 2001-10-17 汤仪 炎疣液
JP5452827B2 (ja) 2000-10-30 2014-03-26 株式会社ファンケル 皮膚賦活用組成物
US20030054047A1 (en) 2001-06-15 2003-03-20 Sanjiu Medical & Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of viral infection
JP2003002989A (ja) 2001-06-19 2003-01-08 Toray Ind Inc プリプレグ
DE60234388D1 (de) 2002-04-15 2009-12-24 Tetsuo Santo Therapeutische lotion gegen dermatitis
AU2002249602A1 (en) 2002-04-15 2003-10-27 Tetsuo Santo Drinking tea for treating dermatitis
CN1316996C (zh) 2002-12-26 2007-05-23 中国医科大学附属第一医院 治疗炎性肠病的复方青黛剂及制备方法
KR20050077310A (ko) * 2004-01-27 2005-08-02 주식회사 엘지생활건강 인디고 추출물을 이용한 모발, 눈썹 및 속눈썹 성장촉진제
CN1586506A (zh) 2004-06-29 2005-03-02 邹卫民 降白口服液
JP5023317B2 (ja) 2005-03-03 2012-09-12 国立大学法人弘前大学 Ｉｖ型アレルギー反応抑制剤
JP2007326855A (ja) * 2006-05-11 2007-12-20 Mitsubishi Gas Chem Co Inc 新規配糖体
KR20090088894A (ko) * 2006-11-24 2009-08-20 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 쪽풀 추출물 분말과 그 제조 방법 및 그 쪽풀 추출물 분말의 용도
PT2405928T (pt) 2009-03-11 2017-02-07 Promedior Inc Métodos de tratamento e de diagnóstico para patologias de hipersensibilidade
CN102247415B (zh) 2010-05-21 2013-09-04 成都中医药大学 一种青黛炮制方法
TWI468169B (zh) 2011-02-18 2015-01-11 Galderma Res & Dev 青黛之經油萃取的產物及其製備方法與用途
TWI438000B (zh) * 2011-02-18 2014-05-21 Galderma Res & Dev 青黛之經油萃取的產物及其製備方法與用途
WO2012124743A1 (ja) 2011-03-14 2012-09-20 サンスター株式会社 藍葉エキス製造方法
MX2013014888A (es) 2011-06-17 2014-02-27 Takeda Gmbh Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida.
CN102351863A (zh) 2011-10-10 2012-02-15 南京泽朗医药科技有限公司 一种从菘蓝中提取青黛酮的方法
KR20130071857A (ko) * 2011-12-21 2013-07-01 원효정 쪽과 황칠나무 추출물을 유효성분으로 포함하는 물티슈 및 일회용 흡수제품과 이의 제조방법
CN103766415A (zh) 2012-10-17 2014-05-07 天津市中科健新材料技术有限公司 一种含壳聚糖的草本抗菌剂
WO2014118040A1 (en) 2013-01-29 2014-08-07 Axel Brattstroem Extract from indigo tinctoria for the topical treatment and prophylaxis of skin disorders
US20140243354A1 (en) * 2013-02-22 2014-08-28 Galderma Research & Development Snc Combinations of indigo naturalis and berberine and uses thereof
EP2961385A4 (en) 2013-02-28 2016-07-27 Prec Dermatology Inc TOPICAL FORMULATIONS OF CORTICOSTEROIDS WITH INCREASED BIOAVAILABILITY
JP6161438B2 (ja) * 2013-07-09 2017-07-12 日本甜菜製糖株式会社 脂肪蓄積抑制及び／又は脂肪蓄積量低減剤
CN103992260A (zh) 2014-05-29 2014-08-20 哈尔滨医科大学 一种从大青叶中提取靛玉红的方法
CN104147309B (zh) * 2014-08-13 2017-12-05 天津开发区天光高科技开发有限公司 一种盐藻素营养组合物及其制备方法
EP3215169A1 (en) 2015-04-09 2017-09-13 Galderma S.A. Treatment of atopic dermatitis with indigo naturalis or indigo producing plant extract
JP6820273B2 (ja) 2015-04-09 2021-01-27 ガルデルマ・ソシエテ・アノニム インジゴ・ナチュラリス由来のエキス及びそれを調製する方法
KR20170132880A (ko) 2015-04-09 2017-12-04 갈데르마 소시에떼아노님 약학 조성물 및 이의 용도

Also Published As

Publication number Publication date
EP3482763A1 (en) 2019-05-15
EP3209313A1 (en) 2017-08-30
CN107427545A (zh) 2017-12-01
US20180099020A1 (en) 2018-04-12
US10695391B2 (en) 2020-06-30
EP3209313B1 (en) 2018-12-19
MX2017012595A (es) 2018-01-09
BR112017021191A2 (pt) 2018-09-25
US20190224264A1 (en) 2019-07-25
BR112017021191B1 (pt) 2021-12-21
CY1121187T1 (el) 2020-05-29
JP2018510890A (ja) 2018-04-19
HRP20190088T1 (hr) 2019-03-22
US20170266248A1 (en) 2017-09-21
CA2981624A1 (en) 2016-10-13
AU2016245203A1 (en) 2017-10-12
HUE041308T2 (hu) 2019-05-28
SI3209313T1 (sl) 2019-03-29
SMT201900054T1 (it) 2019-02-28
TW201642891A (zh) 2016-12-16
LT3209313T (lt) 2019-02-25
PL3209313T3 (pl) 2019-06-28
US9861673B2 (en) 2018-01-09
AU2016245203B2 (en) 2021-07-29
KR20170133497A (ko) 2017-12-05
JP6820273B2 (ja) 2021-01-27
US10251926B2 (en) 2019-04-09
WO2016162484A1 (en) 2016-10-13
TR201901146T4 (tr) 2019-02-21
DK3209313T3 (en) 2019-02-25
PT3209313T (pt) 2019-02-07
TWI732754B (zh) 2021-07-11
ES2709359T3 (es) 2019-04-16
RS58304B1 (sr) 2019-03-29

Similar Documents

Publication Publication Date Title
MX378168B (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
ZA202004557B (en) Modulatory polynucleotides
MX386859B (es) Composiciones farmacéuticas sólidas de antagonistas de los receptores de andrógenos.
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
BR112017010173A2 (pt) composição para tratamento de tecido
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
JO3512B1 (ar) مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
MX2017004219A (es) Uso de carbaldehidos ciclicos novedosos como una sustancia aromatica.
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
BR112017010177A2 (pt) composição para tratamento de tecido
EA201790461A1 (ru) Композиции внеклеточного матрикса
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
CL2016001937A1 (es) Compuestos de benzopirano funcionalizados y uso de los mismos
MX395231B (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos.
MA43650B1 (fr) Formulations/compositions comprenant un inhibiteur de btk
MX390126B (es) Nuevas isoformas de tripsina y su uso.
MX2019005855A (es) Formulaciones que se pueden pulverizar.
MX389026B (es) Una composicion farmaceutica y el uso de la misma.
MX374385B (es) Apilimod para uso en el tratamiento de melanoma.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX391474B (es) Péptidos cíclicos derivados de cd44v6 para el tratamiento de enfermedades relacionadas con cánceres y angiogénesis
MX379126B (es) Formulación de factor viii.